An Open-Label, Randomized Pilot Study Comparing the Safety of a Single Dose of TNX-1300 to Usual Care (UC) Alone for the Treatment of Signs and Symptoms of Acute Cocaine Intoxication in Male Emergency Department (ED) Subjects
Clinical trial NCT04996056 · WITHDRAWN
Trial details
- NCT number
- NCT04996056
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2022-06-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.